Paul Freiman
Chairman chez NOVABAY PHARMACEUTICALS
Fortune : 187 $ au 31/03/2024
Profil
Paul E.
Freiman is the founder of Third Age Pharma LLC, which was founded in 2009.
He holds the title of President at Third Age Pharma LLC starting in 2010.
Dr. Freiman is also the founder of Impressions Holdings LLC.
Dr. Freiman's current job(s) include being the Chairman at NovaBay Pharmaceuticals, Inc. since 2002, a Non-Executive Director at Chronix Biomedical, Inc., and a Director at Phytos, Inc.Dr. Freiman's former job(s) include being the Chairman & Chief Executive Officer at Syntex Corp.
from 1989 to 1995, the President & Chief Executive Officer at Neurobiological Technologies, Inc. from 1997 to 2009, the Co-Chief Executive Officer at Synaptogenix, Inc. in 2014, the Chairman at Penwest Pharmaceuticals Co. from 1997 to 2010, the Chairman at Neurotrope, Inc. from 2013 to 2016, and a Director at NeoPharm, Inc. from 2004 to 2011.
He also held various chairman positions at Digital Gene Technologies, Inc., Pharmaceutical Research & Manufacturers of America, UCSF Foundation, United Way Silicon Valley, and Pharmaceutical Manufacturers Association of America.
Additionally, Dr. Freiman served as a Director at Calypte Biomedical Corp.
from 1997 to 2009, NovaCal Pharmaceuticals, Inc. from 2001 to 2002, SciGen Pte Ltd., OMware, Inc., Otsuka America, Inc., Otsuka America Pharmaceutical, Inc., InSys Therapeutics, Inc. from 2004 to 2011, and INSYS Therapeutics, Inc. in 2010.
Dr. Freiman's education history includes undergraduate studies at Fordham University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 1 783 ( 0,01% ) | 187 $ | 31/03/2024 |
Postes actifs de Paul Freiman
| Sociétés | Poste | Début |
|---|---|---|
| NOVABAY PHARMACEUTICALS | Chairman | 12/03/2019 |
| Phytos, Inc. | Director/Board Member | - |
Third Age Pharma LLC
 Third Age Pharma LLC Miscellaneous Commercial ServicesCommercial Services Third Age Pharma LLC operates as a biotechnology company. The private company is based in San Francisco, CA. The company was founded by Paul E. Freiman. | Founder | 02/07/2010 |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Director/Board Member | - |
Impressions Holdings LLC
 Impressions Holdings LLC Advertising/Marketing ServicesCommercial Services Impressions Holdings LLC operates as holding company whose subsidiaries provide media creation, software development, and lead generation services. The company was founded by Zachary Chen, Paul Freiman, and Gabriele Genghini in 2013 and is headquartered in San Francisco, CA. | Founder | - |
Anciens postes connus de Paul Freiman
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROTROPE, INC. | Chief Executive Officer | 12/09/2014 |
| SYNAPTOGENIX, INC. | Chief Executive Officer | 12/09/2014 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Director/Board Member | 02/05/2011 |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Director/Board Member | 02/05/2011 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Freiman
| Fordham University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEUROBIOLOGICAL TECHNOLOGIES, INC. | Health Technology |
| NOVABAY PHARMACEUTICALS | Health Technology |
| SYNAPTOGENIX, INC. | Health Technology |
| Entreprise privées | 21 |
|---|---|
| Syntex Corp. | Health Technology |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
Calypte Biomedical Corp.
 Calypte Biomedical Corp. Medical SpecialtiesHealth Technology Calypte Biomedical Corp. develops, manufactures and distributes vitro testing products, which improves the diagnosis of Human Immunodeficiency Virus infection, sexually transmitted diseases and other chronic diseases. The company's product line includes both point-of-case rapid tests and the BED incidence test. Calypte Biomedical was founded in 1988 and is headquartered in Portland, OR. | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
NovaCal Pharmaceuticals, Inc.
 NovaCal Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services NovaBay Pharmaceuticals, Inc. used to manufacture pharmaceutical products. It was clinical-stage pharmaceutical company developed a new class of compounds. The company was founded by Anthony Dailley and was headquartered in Emeryville, CA. | Health Services |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
OMware, Inc.
 OMware, Inc. Packaged SoftwareTechnology Services OMware, Inc. developed construction software management solutions. The company was headquartered in Sebastopol, CA. | Technology Services |
Digital Gene Technologies, Inc.
 Digital Gene Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Digital Gene Technologies, Inc. develops technology designed to enable researchers to measure gene expression levels in various disease models. The company is headquartered in La Jolla, CA. | Electronic Technology |
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
UCSF Foundation
 UCSF Foundation Investment Trusts/Mutual FundsMiscellaneous The UCSF Foundation promotes and supports the interests and welfare of the University of California San Francisco and the UCSF Medical Center. The UCSF Foundation’s daily operations are administered by a development staff responsible for major gifts, planned giving, corporate and foundation gifts, annual giving, development communications, alumni relations and campus events | Miscellaneous |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
| Phytos, Inc. | |
United Way Silicon Valley
 United Way Silicon Valley Services to the Health IndustryHealth Services United Way of Silicon Valley operates as a non-profit organization engages in activities to improve the education, income and health of Silicon Valley resident. It is committed to improving community conditions by helping families with children become economically secure, able to support their children’s educational success, physically and emotionally healthy, and connected to the community. The company was founded in 1922 and is headquartered in San Jose, CA. | Health Services |
| Pharmaceutical Manufacturers Association of America | |
Third Age Pharma LLC
Third Age Pharma LLC Miscellaneous Commercial ServicesCommercial Services Third Age Pharma LLC operates as a biotechnology company. The private company is based in San Francisco, CA. The company was founded by Paul E. Freiman. | Commercial Services |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Impressions Holdings LLC
Impressions Holdings LLC Advertising/Marketing ServicesCommercial Services Impressions Holdings LLC operates as holding company whose subsidiaries provide media creation, software development, and lead generation services. The company was founded by Zachary Chen, Paul Freiman, and Gabriele Genghini in 2013 and is headquartered in San Francisco, CA. | Commercial Services |
